pharma news today glp-1 obesity drugs today Market Size to Hit USD 132.79 Bn by 2035 “These are serious medicines…” AIIMS

Prescription trends reflect increasing clinician and patient acceptance, partly driven by robust clinical trial data and heightened public awareness of obesity as a chronic disease

By excluding them from the study, Sodhi said, they were able to tease out more carefully what might be linked to the drug versus the disease

As the field advances, humanized preclinical systems that allow drug evaluation against human targetssuch as GCGR/GIPR/GLP1R humanized mouse modelswill play a pivotal role in bridging the gap between mechanistic discovery and clinical translation

Phentermine is one of the most affordable prescription weight loss medications available

Doctors know more about metformins long-term effects

This meta-analysis explored one in particular, that has a serious impact: Coenzyme Q10 (CoQ10) It analyzed 12 clinical trials involving 362 patients with hypertension